Page last updated: 2024-11-06

lysergic acid diethylamide and Glial Cell Tumors

lysergic acid diethylamide has been researched along with Glial Cell Tumors in 2 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacDermot, J2
Higashida, H2
Wilson, SP1
Matsuzawa, H1
Minna, J1
Nirenberg, M1

Other Studies

2 other studies available for lysergic acid diethylamide and Glial Cell Tumors

ArticleYear
Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids.
    Proceedings of the National Academy of Sciences of the United States of America, 1979, Volume: 76, Issue:3

    Topics: Acetylcholine; Adenylyl Cyclases; Animals; Binding, Competitive; Cell Line; Cell Transformation, Vir

1979
Independent regulation of receptor-mediated cell depolarization and adenylate cyclase by 5-hydroxytryptamine (serotonin) in neuroblastoma hybrid cells [proceedings].
    Biochemical Society transactions, 1979, Volume: 7, Issue:4

    Topics: Adenylyl Cyclases; Animals; Cell Line; Glioma; Hybrid Cells; Lysergic Acid Diethylamide; Mice; Neuro

1979